| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3541614 | ADME | Retention time in human whole blood at 20 uM by LC-MS/MS method | Homo sapiens | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 2. | ALA3541615 | ADME | Retention time in human whole blood in presence of 0.1% formic acid in water at 20 uM by LC-MS/MS method | Homo sapiens | 8 | ALA3526110 | tissue-based format | Scientific Literature | |
| 3. | ALA3541616 | ADME | Retention time in rat whole blood in presence of 0.1% formic acid in water at 20 uM by LC-MS/MS method | Rattus norvegicus | 8 | ALA3526110 | tissue-based format | Scientific Literature | |
| 4. | ALA3541617 | ADME | Retention time in human whole blood in presence of 0.1% formic acid in acetonitrile at 20 uM by LC-MS/MS method | Homo sapiens | 7 | ALA3526110 | tissue-based format | Scientific Literature | |
| 5. | ALA3541618 | ADME | Retention time in rat whole blood in presence of 0.1% formic acid in acetonitrile at 20 uM by LC-MS/MS method | Rattus norvegicus | 7 | ALA3526110 | tissue-based format | Scientific Literature | |
| 6. | ALA3541619 | ADME | Drug metabolism in human whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-3-((2-(3,3-dinitroazetidin-1-yl)-2-oxoethyl)thio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method | Homo sapiens | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 7. | ALA3541620 | ADME | Drug metabolism in rat whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-3-((2-(3,3-dinitroazetidin-1-yl)-2-oxoethyl)thio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method | Rattus norvegicus | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 8. | ALA3541621 | ADME | Drug metabolism in human whole blood assessed as (R)-2-amino-3-((2-(3,3-dinitroazetidin-1-yl)-2-oxoethyl)thio)propanoic acid] formation at 20 uM by LC-MS/MS method | Homo sapiens | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 9. | ALA3541622 | ADME | Drug metabolism in rat whole blood assessed as (R)-2-amino-3-((2-(3,3-dinitroazetidin-1-yl)-2-oxoethyl)thio)propanoic acid] formation at 20 uM by LC-MS/MS method | Rattus norvegicus | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 10. | ALA3541623 | ADME | Drug metabolism in human whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-3-((2-(3-nitroazetidin-1-yl)-2-oxoethyl)thio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method | Homo sapiens | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 11. | ALA3541624 | ADME | Drug metabolism in rat whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-3-((2-(3-nitroazetidin-1-yl)-2-oxoethyl)thio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method | Rattus norvegicus | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 12. | ALA3541625 | ADME | Drug metabolism in human whole blood assessed as [(R)-2-amino-3-((2-(3-nitroazetidin-1-yl)-2-oxoethyl)thio)propanoic acid] formation at 20 uM by LC-MS/MS method | Homo sapiens | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 13. | ALA3541626 | ADME | Drug metabolism in rat whole blood assessed as [(R)-2-amino-3-((2-(3-nitroazetidin-1-yl)-2-oxoethyl)thio)propanoic acid] formation at 20 uM by LC-MS/MS method | Rattus norvegicus | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 14. | ALA3541627 | ADME | Drug metabolism in human whole blood assessed as [(R)-2-(2-amino-3-((2-(3,3-dinitroazetidin-1-yl)-2-oxoethyl)thio)propanamido)acetic acid] formation at 20 uM by LC-MS/MS method | Homo sapiens | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 15. | ALA3541628 | ADME | Drug metabolism in rat whole blood assessed as [(R)-2-(2-amino-3-((2-(3,3-dinitroazetidin-1-yl)-2-oxoethyl)thio)propanamido)acetic acid] formation at 20 uM by LC-MS/MS method | Rattus norvegicus | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 16. | ALA3541629 | ADME | Drug metabolism in human whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-1-oxo-3-((2-oxo-2-(3-oxoazetidin-1-yl)ethyl)thio)propan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method | Homo sapiens | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 17. | ALA3541630 | ADME | Drug metabolism in rat whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-1-oxo-3-((2-oxo-2-(3-oxoazetidin-1-yl)ethyl)thio)propan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method | Rattus norvegicus | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 18. | ALA3541631 | ADME | Drug metabolism in human whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-3-((2-(3-(hydroxyimino)azetidin-1-yl)-2-oxoethyl)thio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method | Homo sapiens | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 19. | ALA3541632 | ADME | Drug metabolism in rat whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-3-((2-(3-(hydroxyimino)azetidin-1-yl)-2-oxoethyl)thio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method | Rattus norvegicus | 1 | ALA3526110 | tissue-based format | Scientific Literature | |
| 20. | ALA3541635 | ADME | Binding affinity to human hemoglobin assessed as alkylation on Hb beta chain Cys-93 locus at 0.53 to 5.5 mM by LC-MS/MS method | Homo sapiens | 1 | ALA3526110 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!